Saw palmetto study
This article was originally published in The Tan Sheet
Executive Summary
Saw palmetto use may shrink prostate tissue, conclude Leonard Marks, MD, et al., American Urological Association, in a study presented at the AUA annual meeting May 2-5 in Dallas, Tex. The six-month, double-blind trial tested the effects of a saw palmetto dietary supplement on 44 men with benign prostatic hyperplasia. The researchers in the study of prostate biopsy specimens suggest "saw palmetto extract appears to exert a suppressant effect" in the "transition zone epithelium, from 17.8% before to 10.7% after six months of treatments." Modest symptom scores of BPH and maximum flow within the prostate also were better than placebo. The study was supported by the Nutrilite division of Amway, who provided its 320 mg Nutrilite Saw Palmetto with Nettle Root
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning